Pancreatic Cancer Research

ResearcherTechnische Universität DresdenActive in the last 2 years

Luise Rupp

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6610-326X; OpenAlex author ID A5078153273. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fimmu.2024.1378190↗
  2. VISTA Ligation Reduces Antitumor T-Cell Activity in Pancreatic Cancer. Co-author DOI 10.3390/cancers15082326↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Marc Schmitz · 2 shared papers, 2023–2024 · strength 0.34
  2. Helmut Frieß · 1 shared paper, 2024 · strength 0.18
  3. Maximilian Kießler · 1 shared paper, 2024 · strength 0.18
  4. Alexander Muckenhuber · 1 shared paper, 2024 · strength 0.18
  5. Casper W.F. van Eijck · 1 shared paper, 2024 · strength 0.18
  6. Carmen Mota Reyes · 1 shared paper, 2024 · strength 0.18
  7. Casper H.J. van Eijck · 1 shared paper, 2024 · strength 0.18
  8. İhsan Ekin Demir · 1 shared paper, 2024 · strength 0.18
  9. Ioana Plesca · 1 shared paper, 2023 · strength 0.16
  10. David Digomann · 1 shared paper, 2023 · strength 0.16
  11. Adrian M. Seifert · 1 shared paper, 2023 · strength 0.16
  12. Max Heiduk · 1 shared paper, 2023 · strength 0.16
  13. Lena Seifert · 1 shared paper, 2023 · strength 0.16
  14. Jürgen Weitz · 1 shared paper, 2023 · strength 0.16
  15. Marius Distler · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.